Bioglan, Hexal AG deal

BGP will buy from Hexal a portfolio of 12 dermatology products marketed in Germany for £16.4 million ($24.5 million), including 1.85 million BGP shares and £7.9 million in cash. BGP also will pay Hexal up to DM7 million ($3.4 million) in royalties. The portfolio had sales of DM15 million ($7.2 million) for the year ending July 2000. ...